The microbiome revolution

Journal of Clinical Investigation

Volumn 124, Issue 10, 2014, Pages 4162-4165

  Blaser, Martin J ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; XENOBIOTIC AGENT; ANTIINFECTIVE AGENT; DRUG; PROBIOTIC AGENT;

BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; CARCINOGENESIS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMMENSALISM; DRUG METABOLISM; HEALTH CARE COST; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOPATHOGENESIS; INFLAMMATORY DISEASE; METABOLIC DISORDER; MICROBIAL METABOLISM; MICROBIOME; MICROFLORA; ORGANISMAL INTERACTION; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; CHEMISTRY; GASTROINTESTINAL TRACT; INFLAMMATION; METABOLISM; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE;

ANTI-BACTERIAL AGENTS; CARCINOGENESIS; CLOSTRIDIUM DIFFICILE; GASTROINTESTINAL TRACT; HUMANS; IMMUNITY; INFLAMMATION; MICROBIAL INTERACTIONS; MICROBIOTA; PHARMACEUTICAL PREPARATIONS; PROBIOTICS; XENOBIOTICS;

EID: 84907487932     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI78366     Document Type: Review

References (60)

1. Lederberg J. Infectious history. Science. 2000;288(5464):287-293.
2. Mackowiak PA. The normal microbial flora. N Engl J Med. 1982;307(2):83-93.
3. Rosebury T. Life On Man. New York, New York, USA: Viking Adult; 1969.
4. Bohnoff M, Drake B, Miller C. Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection. Proc Soc Exp Biol Med. 1954;86(1):132-137.
5. Dubos RJ, Savage DC, Schaedler RW. The indigenous flora of the gastrointestinal tract. Dis Colon Rectum. 1967;10(1):23-34.
6. Savage DC. The microbial flora in the gastrointestinal tract. Prog Clin Biol Res. 1981;77:893-908.
7. Beard A, Blaser MJ. The ecology of height: the effect of microbial transmission on human height. Perspect Biol Med. 2002;45(4):475-498.
8. Bäckhed F, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101(44):15718-15723.
9. Blaser MJ. Who are we? Indigenous microbes and the ecology of human diseases. EMBO Rep. 2006;7(10):956-960.
10. Dethlefsen L, McFall-Ngai M, Relman D. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 2007;449(7164):811-818.
11. Blaser MJ, Kirschner D. The equilibria that permit bacterial persistence in human hosts. Nature. 2007;449(7164):843-849.
12. Barton ES, et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature. 2007;447(7142):326-329.
13. Fukuda S, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469(7331):543-547.
14. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207-214.
15. The Human Microbiome Project Consortium. A framework for human microbiome research. Nature. 2012;486(7402):215-221.
16. Reyes A, et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature. 2010;466(7304):334-338.
17. Minot S, et al. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 2011;21(10):1616-1625.
18. Pride DT, et al. Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome. ISME J. 2011;6(5):915-926.
19. Minot S, Bryson A, Chehoud C, Wu GD, Lewis JD, Bushman FD. Rapid evolution of the human gut virome. Proc Natl Acad Sci U S A. 2013;110(30):12450-12455.
20. Wylie KM, Mihindukulasuriya KA, Zhou Y, Sodergren E, Storch GA, Weinstock GM. Metagenomic analysis of double-stranded DNA viruses in healthy adults. BMC Biol. In press.
21. Yoshimoto S, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499(7456):97-101.
22. Joyce SA, et al. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc Natl Acad Sci U S A. 2013;111(20):7421-7426.
23. Davey KJ, et al. Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl Psychiatry. 2013;3:e309.
24. David LA, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559-563.
25. Ridaura V, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341(6150):1241214.
26. Le Chatilier E, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541-546.
27. Findley K, et al. Topographic diversity of fungal and bacterial communities in human skin. Nature. 2013;498(7454):367-370.
28. Kraal S, Abubuker S, Kota K, Fischbach MA. The prevalence of species and strains in the human microbiome: a resource for experimental efforts. PLoS One. 2014;9(5):e97279.
29. Sharon I, Morowitz MJ, Thomas BC, Costello EK, Relman DA, Banfield JF. Time series community genomics analysis reveals rapid shift in bacterial species, strains, and phage during infant gut colonization. Genome Res. 2013;23(1):111-120.
30. Koren O, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150(3):470-480.
31. Chung H, et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell. 2012;149(7):1578-1593.
32. Modi SR, Lee HH, Spina CS, Collins JJ. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature. 2013;499(7457):219-222.
33. Ivanov II, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(3):485-498.
34. Wu HJ, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity. 2010;32(6):815-827.
35. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ. Infant antibiotic exposures and early life body mass. Int J Obes (Lond). 2013;37(1):16-23.
36. Blustein J, et al. Caesarian delivery and child adiposity. Int J Obes (Lond). 2013;37(7):900-906.
37. Van Nood E, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407-415.
38. Antharam VC, et al. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J Clin Microbiol. 2013;51(9):2884-2892.
39. Modi SR, Collins JJ, Relman DA. Antibiotics and the gut microbiota. J Clin Invest. 2014;124(10):4212-4218.
40. Hviid A, Svanstrom H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut. 2011;60(1):49-54.
41. Kozyrskyj AL, Ernst P, Becker AB. Increased risk of childhood asthma from antibiotic use in early life. Chest. 2007;131(6):1753-1759.
42. Cox LM, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 2014;158(4):705-721.
43. Seekatz AM, Young VB. Clostridium difficile and the microbiota. J Clin Invest. 2014;124(10):4182-4819.
44. Carmody RN, Turnbaugh PJ. Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J Clin Invest. 2014;124(10):4173-4181.
45. Wallace BD, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science. 2010;330(6005):831-835.
46. Marchant A, Goldman M. T cell-mediated immune responses in human newborns: ready to learn? Clin Exper Immunol. 2005;141(1):10-18.
47. Surana NK, Kasper DL. Deciphering the tête-è-tête between the microbiota and the immune system. J Clin Invest. 2014;124(10):4197-4203.
48. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81(3):1031-1064.
49. Tang W H W, Hazen SL. The contributory role of gut microbiota in cardiovascular disease. J Clin Invest. 2014;124(10):4204-4211.
50. Dalal SR, Chang EB. The microbial basis of inflammatory bowel diseases. J Clin Invest. 2014;124(10):4190-4196.
51. Sears CL, Geis AL, Housseau F. Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis. J Clin Invest. 2014;124(10):4166-4172.
52. Kamangar F, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst. 2006;98(20):1445-1452.
53. Cho I, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012;488(7413):621-626.
54. Reyes A, Wu M, McNulty NP, Rohwer FL, Gordon JI. Gnotobiotic mouse model of phage-bacterial host dynamics in the human gut. Proc Natl Acad Sci U S A. 2013;110(50):20236-20241.
55. Barr JJ, et al. Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc Natl Acad Sci U S A. 2013;110(26):10771-10776.
56. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011;12(8):453-466.
57. Bravo JA, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050-16055.
58. Diaz Heijtz R, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011;108(7):3047-3052.
59. Caporaso JG, et al. QIIME allows analysis of highthroughput community sequencing data. Nat Methods. 2010;7(5):335-336.
60. Schloss PD, et al. Introducing mothur: opensource, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75(23):7537-7541.